3 completed. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 1 | Completed 1 |
Follow Treatment B: new trials by email Literature Review of Treatment B trials Research Report on Treatment B
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| P-glypoprotein Inhibition Effect on the Pharmacokinetics of Two Tacrolimus Formulations: Prolonged and Extended-release Treatment A, Treatment B, Treament C - Pharmacokinetics | Phase 2 | Completed | Rennes University Hospital | 27 | 2022-02-15 | 2024-12-11 |
| A Phase 2a Study to Assess Safety, Daily Symptoms, PK, and Biomarkers of YPL-001 in COPD Patients YPL-001 80 mg, YPL-001 160 mg, Placebo - Chronic Obstructive Pulmonary Disease | Phase 2 | Completed | Yungjin Pharm. Co., Ltd. | 61 | 2015-06-04 | 2023-07-14 |
| HEMOTOL: Efficacy and Safety of Hemodialysis On-line Monitoring Devices on Hemodynamic Stability in Intensive Care Unit Standard Hemodialysis, with Blood Volume Management (BVM®) only, with Blood Volume (BVM®) and Temperature (BTM®) on-line monitoring - Hemodialysis | Phase 2 / Phase 3 | Completed | University Hospital, Caen | 600 | 2008-12-01 | 2010-03-03 |
Acute Kidney Injury (1) · Hypotension (1) · Pulmonary Disease, Chronic Obstructive (1)
Rennes University Hospital (1) · University Hospital, Caen (1) · Yungjin Pharm. Co., Ltd. (1)
France (2) · United States (1)
Gerard J Criner, MD (1) · Mark T Dransfield, MD (1)
PMID 22535635, PMID 26318254, PMID 28011397, PMID 29496167, PMID 36670877, PMID 39498822